Fukuda M, Kameyama S, Kawaguchi T, Yamashita S, Tanaka R
Department of Neurosurgery, National Nishi-Niigata Chuo Hospital, Japan.
No Shinkei Geka. 1998 Aug;26(8):709-15.
A series of 30 patients, who underwent stereotactic surgery for movement disorder under intravenous propofol anesthesia between March, 1995 and December, 1997, was retrospectively reviewed. In 28 patients with Parkinson's disease including seven juvenile cases of parkinsonism, the postoperative motor and ADL scores on the Unified Parkinson's Disease Rating Scale significantly improved. In the other two patients, one of whom had severe posttraumatic tremor and the other had cerebral palsy, the stereotactic surgery produced considerable alleviation of their symptoms. We evaluated and discussed the usefulness of intravenous propofol anesthesia in stereotaxy. Except for one patient who had an allergic reaction against propofol, none of the patients complained of intraoperative pain postoperatively. Wake-up tests were performed to record neural noise levels in 26 cases. This recording was performed under propofol anesthesia in two cases with advanced Parkinson's disease and one with cerebral palsy. In these patients, neural noise levels were recorded and were useful for identifying the target. Although the tremor disappeared under propofol anesthesia in 17 patients presenting with moderate or severe tremor, it was presented again after discontinuation of propofol. Wake-up test, therefore, made a good evaluation of Vim thalamotomy for tremor. In juvenile parkinsonian patients, three presented with dopa-induced dyskinesia (DID) during propofol infusion. In two of them, the DID emerged immediately after posteroventral pallidotomy and continued 4 or 10 hours after stereotaxy. These findings suggest that propofol possibly has an anti-parkinsonian effect. Intravenous propofol anesthesia is a useful method to use with stereotactic surgery for movement disorders.
回顾性分析了1995年3月至1997年12月期间在静脉注射丙泊酚麻醉下接受立体定向手术治疗运动障碍的30例患者。在28例帕金森病患者中,包括7例青少年帕金森综合征患者,术后统一帕金森病评定量表的运动和日常生活活动评分显著改善。另外2例患者,1例患有严重创伤后震颤,另1例患有脑瘫,立体定向手术使他们的症状得到了相当程度的缓解。我们评估并讨论了静脉注射丙泊酚麻醉在立体定向手术中的实用性。除1例对丙泊酚过敏的患者外,所有患者术后均未抱怨术中疼痛。对26例患者进行了唤醒试验以记录神经噪声水平。在2例晚期帕金森病患者和1例脑瘫患者中,在丙泊酚麻醉下进行了该记录。在这些患者中,记录了神经噪声水平,有助于确定靶点。尽管17例中度或重度震颤患者在丙泊酚麻醉下震颤消失,但丙泊酚停药后震颤再次出现。因此,唤醒试验对丘脑腹中间核毁损术治疗震颤的效果进行了良好的评估。在青少年帕金森病患者中,3例在丙泊酚输注期间出现多巴诱导的运动障碍(DID)。其中2例在腹后苍白球切开术后立即出现DID,并在立体定向手术后持续4或10小时。这些发现表明丙泊酚可能具有抗帕金森病作用。静脉注射丙泊酚麻醉是立体定向手术治疗运动障碍的一种有用方法。